5Mufioz M, Rosso M. The NK 1 receptor antagonist aprepi- tant as a broad spectrum antitumor drug[J]. Invest New Drugs,2010,28(2) :187-193.
6Hickok J T, Roscoe J A, Morrow G R, et al. 5 Hydroxytryptamine-receptor antagonists versus prochlor perazine {or control o{ delayed nausea caused by doxoru bicin: a URCC CCOP randomised controlled trial[J] Lancet Oncol,2005,6(10) :765 772.
7Chan V T, Yeo W. Antiemetic therapy options for che- motherapy-induced nausea and vomiting in breast cancer patients[J]. Breast Cancer (Dove Med Press),2011,3: 151-160.
8Charles A H, William J T, David L L. Efficacy of beha- vioral self-management techniques with adolescents with learning disabilities and behavior disorders[J]. Advances in Learning and Behavioral Disabilities, 2004, 17 ( 1 ) : 1- 28.
9Hendrix C, Abernethy A, Sloane R, et al. A pilot study on the influence of an individualized and experiential training on cancer caregivers self- efficacy in home care and symptom management [ J ]. Tie Healthy Nurse, 2009,27 ( 5 ) : 271 - 278.
10Pinto BM,Rabin C, Dunsiger S. Home based exercise among cancer survivors : adherence and its predictors [J].Psycho Oneolgy, 2009,18 (4) : 369 - 376.
